Financial statements Bud-Drog
Balance sheet data of BUD-DROG
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 16 422,94 | 9 696,23 | 3 255,41 | 1 801,38 | 1 345,12 | 5 740,93 |
| A. Fixed assets | 3 198,00 | 1 599,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 13 224,94 | 8 097,23 | 3 255,41 | 1 801,38 | 1 345,12 | 5 740,93 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 16 422,94 | 9 696,23 | 3 255,41 | 1 801,38 | 1 345,12 | 5 740,93 |
| A. Equity | 6 928,71 | 8 741,75 | 2 108,67 | -28 231,72 | -31 780,24 | -27 655,38 |
| B. Liabilities and provisions for liabilities | 9 494,23 | 954,48 | 1 146,74 | 30 033,10 | 33 125,36 | 33 396,31 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 9 494,23 | 954,48 | 1 146,74 | 30 033,10 | 33 125,36 | 33 396,31 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.